Found: 18
Select item for more details and to access through your institution.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 4, p. 837, doi. 10.3390/ijms18040837
- By:
- Publication type:
- Article
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxestan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase 2 study of CHOP-R-14 followed by <sup>90</sup>Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 4, p. 627, doi. 10.3892/mco.2017.1169
- By:
- Publication type:
- Article
MPN-280: Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Male with Heavily Pretreated INT-2 Primary Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S359, doi. 10.1016/S2152-2650(21)01828-0
- By:
- Publication type:
- Article
Poster: MPN-280: Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Male with Heavily Pretreated INT-2 Primary Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S235, doi. 10.1016/S2152-2650(21)01483-X
- By:
- Publication type:
- Article
Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ.
- Published in:
- Journal of Patient-Reported Outcomes, 2021, v. 5, n. 1, p. 1, doi. 10.1186/s41687-021-00376-0
- By:
- Publication type:
- Article
Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 425, doi. 10.2147/JBM.S361863
- By:
- Publication type:
- Article
Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04518-9
- By:
- Publication type:
- Article
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03513-4
- By:
- Publication type:
- Article
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0491-2
- By:
- Publication type:
- Article
New Approaches to Diagnosing and Treating Myelofibrosis.
- Published in:
- Clinical Advances in Hematology & Oncology, 2011, v. 9, n. 9, p. 10
- By:
- Publication type:
- Article
New Approaches to Diagnosing and Treating Myelofibrosis.
- Published in:
- Clinical Advances in Hematology & Oncology, 2011, v. 9, p. 10
- By:
- Publication type:
- Article
Clinical and Laboratory Features of Myelofibrosis and Limitations of Current Therapies.
- Published in:
- Clinical Advances in Hematology & Oncology, 2011, v. 9, p. 1
- By:
- Publication type:
- Article
Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions.
- Published in:
- 2016
- By:
- Publication type:
- journal article